Advertisement

Topics

Epilepsy Market in the US 20152019 Prices from USD $2500

15:32 EST 1 Dec 2016 | BioPortfolio Reports

About Epilepsy
Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and lifethreatening symptoms. It is caused by various factors ranging from brain malformations and tumors to meningitis, highrisk pregnancies, and birth trauma. However, when the underlying cause of the disease is unidentified, as in the majority of the cases, it is known as idiopathic epilepsy. Epilepsy is characterized by repeated occurrence of generalized or focal seizures. An imbalance between the inhibitory and excitatory signals of the brain, leading to a sudden onset of excitation, results in seizures. Occurrence of two or more unprovoked seizures is an important criterion to diagnose a person as being epileptic.
TechNavio's analysts forecast the Epilepsy market in the US to grow at a CAGR of 4.85 percent over the period 20142019.
Covered in this Report
The Epilepsy market in the US can be divided into three segments: Firstgeneration Drugs, Secondgeneration Drugs, and Thirdgeneration Drugs. This report covers the present scenario and the growth prospects of the Epilepsy market in the US for the period 20152019. To calculate the market size, the report considers the revenue generated through the sales of antiepileptic drugs approved in the US to treat the symptoms of epilepsy.
TechNavio's report, Epilepsy Market in the US 20152019, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the landscape of the Epilepsy Market in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Vendors
GlaxoSmithKline
Pfizer
UCB
Market Driver
Unmet Medical Needs
For a full, detailed list, view our report
Market Challenge
Generic Erosion
For a full, detailed list, view our report
Market Trend
Reformulation of Marketed Drugs
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Original Article: Epilepsy Market in the US 20152019 Prices from USD $2500

NEXT ARTICLE

More From BioPortfolio on "Epilepsy Market in the US 20152019 Prices from USD $2500"

Quick Search
Advertisement
 

Relevant Topics

Epilepsy
Epilepsy is defined as a disorder of brain function characterized by recurrent seizures that have a sudden onset.  (Oxford Medical Dictionary).  A seizure is caused by a sudden burst of excess electrical activity in the brain, causing a tempora...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...